KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy
Authors
Keywords
-
Journal
BRAIN
Volume 141, Issue 5, Pages 1390-1403
Publisher
Oxford University Press (OUP)
Online
2018-02-24
DOI
10.1093/brain/awy071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carvacrol after status epilepticus (SE) prevents recurrent SE, early seizures, cell death, and cognitive decline
- (2017) Aytakin Khalil et al. EPILEPSIA
- Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice
- (2017) Katarzyna Socała et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding
- (2016) Carlos Huerta et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function
- (2016) Noemí Esteras et al. BIOLOGICAL CHEMISTRY
- Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau
- (2016) Shi-jie Liu et al. BRAIN
- Functional role of mitochondrial reactive oxygen species in physiology
- (2016) Plamena R. Angelova et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis (cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action
- (2015) Rumen V. Kostov et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nrf2 regulates ROS production by mitochondria and NADPH oxidase
- (2015) Stjepana Kovac et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The emerging role of Nrf2 in mitochondrial function
- (2015) Albena T. Dinkova-Kostova et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sulforaphane is anticonvulsant and improves mitochondrial function
- (2015) Catalina Carrasco-Pozo et al. JOURNAL OF NEUROCHEMISTRY
- Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy
- (2015) Shane Rowley et al. NEUROBIOLOGY OF DISEASE
- Status epilepticus results in persistent overproduction of reactive oxygen species, inhibition of which is neuroprotective
- (2015) S. Williams et al. NEUROSCIENCE
- Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications
- (2014) Joanne Walsh et al. Journal of Proteomics
- Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
- (2014) Anne Cleasby et al. PLoS One
- Chemical Tuning Enhances Both Potency Toward Nrf2 and In Vitro Therapeutic Index of Triterpenoids
- (2014) Ian M. Copple et al. TOXICOLOGICAL SCIENCES
- Seizure activity results in calcium- and mitochondria-independent ROS production via NADPH and xanthine oxidase activation
- (2014) S Kovac et al. Cell Death & Disease
- Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy
- (2013) Manuela Mazzuferi et al. ANNALS OF NEUROLOGY
- Post-treatment of an NADPH oxidase inhibitor prevents seizure-induced neuronal death
- (2013) Jin Hee Kim et al. BRAIN RESEARCH
- Activation of Nrf2-ARE signal pathway in hippocampus of amygdala kindling rats
- (2013) Wei Wang et al. NEUROSCIENCE LETTERS
- Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration
- (2013) K. M. Holmstrom et al. Biology Open
- Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE
- (2012) Bianca Jupp et al. EPILEPSIA
- Identification of new epilepsy treatments: Issues in preclinical methodology
- (2012) Aristea S. Galanopoulou et al. EPILEPSIA
- Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy
- (2012) Uwe Heinemann et al. GLIA
- Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death
- (2012) S. Kovac et al. JOURNAL OF CELL SCIENCE
- Post-Translational Oxidative Modification and Inactivation of Mitochondrial Complex I in Epileptogenesis
- (2012) K. Ryan et al. JOURNAL OF NEUROSCIENCE
- Increased perivascular laminin predicts damage to astrocytes in CA3 and piriform cortex following chemoconvulsive treatments
- (2012) F. Gualtieri et al. NEUROSCIENCE
- The cytoprotective role of the Keap1–Nrf2 pathway
- (2011) Liam Baird et al. ARCHIVES OF TOXICOLOGY
- Tricyclic Compounds Containing Nonenolizable Cyano Enones. A Novel Class of Highly Potent Anti-Inflammatory and Cytoprotective Agents(79)
- (2011) Tadashi Honda et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel telemetry system for recording EEG in small animals
- (2011) Pishan Chang et al. JOURNAL OF NEUROSCIENCE METHODS
- Mechanisms of epileptogenesis and potential treatment targets
- (2011) Asla Pitkänen et al. LANCET NEUROLOGY
- Metabolism and Tissue Distribution of Sulforaphane in Nrf2 Knockout and Wild-Type Mice
- (2011) John D. Clarke et al. PHARMACEUTICAL RESEARCH
- The cap’n’collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics
- (2010) Larry G. Higgins et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The role of inflammation in epilepsy
- (2010) Annamaria Vezzani et al. Nature Reviews Neurology
- Development of Spontaneous Recurrent Seizures after Kainate-Induced Status Epilepticus
- (2009) P. A. Williams et al. JOURNAL OF NEUROSCIENCE
- The global burden and stigma of epilepsy
- (2008) Hanneke M. de Boer et al. EPILEPSY & BEHAVIOR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation